Cancer Greek Test
The cancer Greek test or R.G.C.C, is now available at Reno Integrative Medical Center for those wanting a more specific cancer profile test.
- Detect early signs of developing cancer
- Help monitoring existing cancers
- produce an individual profile of chemotherapeutic drugs and natural substances that can be used to achieve the best treatment outcomes.
Circulating Tumor Cells
Circulating Tumor Cells (CTC’s) are cells that have detached from the primary tumor and flow into the blood or lymphatic circulation creating a secondary tumor. Despite their rare population, these cells exhibit metastatic attributes and are related to cancer progression.
Detecting and isolating them is a priority of many research projects and although there has been great progress made in this area there are many drawbacks associated with sensitivity and specificity of different methodologies. RGCC Group has established a new alternative fluidic-based method, called the cancer Greek test, with 86.6% sensitivity and 83.3% specificity among different types of cancer.
There is a growing interest in personalized cancer treatments and the identification of suitable treatments that may work for each cancer patient.
Chemosensitivity testing is one method of doing this. This involves testing an individual’s cancer cells in the laboratory to identify which drugs and natural substances demonstrate the best response.
This is a blood test (or in some cases tissue tests). Tumor cells are identified and isolated from the sample for the following analysis:
- Viable testing of chemotherapy drugs
- Genetic profiling for guidance about targeted therapies e.g. monoclonal antibodies.
- Viability testing (and identification of mechanisms of action), of natural substances which may be used as part of a complementary treatment strategy.
Cancer Greek Test results
The results are presented in a written report which the doctor can use to help guide treatment options and choices. In addition, R.G.C.C. Group can provide information about how an individual will “handle” specific chemotherapy agents.
Our genetic make-up determines whether we are “accumulators” or “rapid metabolizers” of certain drugs. This can play a critical role in determining how effective a specific treatment is likely to be for us, and how significant the side effects will be.
*If you are interested in this test, please fill out the form below and our patient liaison will contact you with more information.